TCR2 Therapeutics
TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.
1
Funding Rounds
$125.0m
Money raised
Overview
TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.
- Website:
- Headquarters: Cambridge, Massachusetts
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Sh*** To******* | - | - | - |
| Ga*** Me**** | - | - | |
| An**** Al*** | - | - | - |
| An***** Ga***** | - | - |
Industries
TCR2 Therapeutics is active in the following industries:
- Engineering
- Immunotherapy
- Cancer immunotherapy
- Healthcare
- Biomedical engineering
- Biopharmaceutical
- Technology
- Biotechnology
- Biology
- Regenerative medicine
- Internal medicine
- Oncology
- Genomics
- Genome editing
- Cell therapy